{"protocolSection":{"identificationModule":{"nctId":"NCT06903338","orgStudyIdInfo":{"id":"VIR-CHDV-V203"},"organization":{"fullName":"Vir Biotechnology, Inc.","class":"INDUSTRY"},"briefTitle":"A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection","officialTitle":"A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart + Elebsiran Combination Therapy in Participants With Chronic HDV Infection (ECLIPSE 1)"},"statusModule":{"statusVerifiedDate":"2025-11","overallStatus":"ACTIVE_NOT_RECRUITING","startDateStruct":{"date":"2025-03-12","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2026-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2031-05","type":"ESTIMATED"},"studyFirstSubmitDate":"2025-03-24","studyFirstSubmitQcDate":"2025-03-24","studyFirstPostDateStruct":{"date":"2025-03-30","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-11-12","lastUpdatePostDateStruct":{"date":"2025-11-14","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Vir Biotechnology, Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false,"isUsExport":true},"descriptionModule":{"briefSummary":"This is a multicenter, open label, randomized Phase 3 clinical study to evaluate the efficacy and safety of the combination of tobevibart + elebsiran for the treatment of chronic hepatitis delta in comparison to delayed treatment."},"conditionsModule":{"conditions":["Viral Hepatitis"],"keywords":["HDV","Hepatitis D Virus","Hepatitis","Chronic Hepatitis D Virus","Hepatitis D","Hepatitis D, Chronic","Hepatitis Delta Virus"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":124,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Arm 1 (Tobevibart + Elebsiran)","type":"EXPERIMENTAL","description":"Participants will receive treatment with tobevibart + elebsiran for 240 weeks.","interventionNames":["Drug: Tobevibart","Drug: Elebsiran"]},{"label":"Arm 2 (Tobevibart + Elebsiran)","type":"EXPERIMENTAL","description":"Participants will receive tobevibart + elebsiran after an observational period for 240 weeks.","interventionNames":["Drug: Tobevibart","Drug: Elebsiran"]}],"interventions":[{"type":"DRUG","name":"Tobevibart","description":"Tobevibart administered by subcutaneous injection","armGroupLabels":["Arm 1 (Tobevibart + Elebsiran)","Arm 2 (Tobevibart + Elebsiran)"],"otherNames":["VIR-3434"]},{"type":"DRUG","name":"Elebsiran","description":"Elebsiran administered by subcutaneous injection","armGroupLabels":["Arm 1 (Tobevibart + Elebsiran)","Arm 2 (Tobevibart + Elebsiran)"],"otherNames":["VIR-2218"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"HDV RNA < Lower Limit of Quantification (LLOQ), Target Not Detected (TND) and alanine aminotransferase (ALT) normalization (ALT </= Upper Limit of Normal [ULN]) at Week 48 for Arm 1 vs at Week 12 for Arm 2","timeFrame":"Up to 48 weeks"},{"measure":"Incidence of Treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs) through Week 12","timeFrame":"Up to 12 weeks"}],"secondaryOutcomes":[{"measure":"HDV RNA < LLOQ, TND at Week 48 for Arm 1 vs Week 12 for Arm 2","timeFrame":"Up to 48 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Male or female ages 18 to 70 years at screening\n2. Chronic HDV infection for \\>/= 6 months\n3. On NRTI therapy against HBV for at least 12 weeks prior to day 1 or have HBV DNA \\< 20 IU/ml at screening, currently on locally approved NRTI therapy\n4. Serum ALT \\> ULN and \\< 5x ULN\n5. Non-cirrhotic or Compensated Cirrhotic Liver Disease at screening\n\nExclusion Criteria:\n\n1. Any clinically significant chronic or acute medical or psychiatric condition that makes the participant unsuitable for participation.\n2. History of significant liver disease from non-HBV or non-HDV etiology\n3. History of allergic reactions, hypersensitivity, or intolerance to study drug, its metabolites, or excipients.\n4. History of anaphylaxis\n5. History of immune complex disease\n6. History of autoimmune disorder\n7. History or evidence of alcohol or drug abuse within 6 months before screening or a positive drug screen at screening unless it can be explained by a prescribed medication","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Investigative Site","city":"Chandler","state":"Arizona","zip":"85224","country":"United States","geoPoint":{"lat":33.30616,"lon":-111.84125}},{"facility":"Investigative Site","city":"Los Angeles","state":"California","zip":"90033","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"Investigative Site","city":"Redwood City","state":"California","zip":"94063","country":"United States","geoPoint":{"lat":37.48522,"lon":-122.23635}},{"facility":"Investigative Site","city":"San Francisco","state":"California","zip":"94143","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"Investigative Site","city":"DeLand","state":"Florida","zip":"32720","country":"United States","geoPoint":{"lat":29.02832,"lon":-81.30312}},{"facility":"Investigative Site","city":"Chicago","state":"Illinois","zip":"60612","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"Investigative Site","city":"Baltimore","state":"Maryland","zip":"21287","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"Investigative Site","city":"Hillsborough","state":"New Jersey","zip":"08844","country":"United States","geoPoint":{"lat":40.4776,"lon":-74.62682}},{"facility":"Investigative Site","city":"New York","state":"New York","zip":"10016","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Investigative Site","city":"New York","state":"New York","zip":"10021","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Investigative Site","city":"New York","state":"New York","zip":"10029","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Investigative Site","city":"Murray","state":"Utah","zip":"84107","country":"United States","geoPoint":{"lat":40.66689,"lon":-111.88799}},{"facility":"Investigative Site","city":"Seattle","state":"Washington","zip":"98105","country":"United States","geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"Investigative Site","city":"Calgary","state":"Alberta","zip":"T2N 4Z6","country":"Canada","geoPoint":{"lat":51.05011,"lon":-114.08529}},{"facility":"Investigative Site","city":"Montreal","state":"Quebec","zip":"H2L 4E9","country":"Canada","geoPoint":{"lat":45.50884,"lon":-73.58781}},{"facility":"Investigative Site","city":"Montreal","zip":"H2X 1R9","country":"Canada","geoPoint":{"lat":45.50884,"lon":-73.58781}},{"facility":"Investigative Site","city":"Ottawa","zip":"K1H8L6","country":"Canada","geoPoint":{"lat":45.41117,"lon":-75.69812}},{"facility":"Investigative Site","city":"QuÃ©bec","zip":"G1V 4G2","country":"Canada","geoPoint":{"lat":46.81228,"lon":-71.21454}},{"facility":"Investigative Site","city":"Vancouver","zip":"V6Z 2C7","country":"Canada","geoPoint":{"lat":49.24966,"lon":-123.11934}},{"facility":"Investigative Site","city":"Tbilisi","zip":"0102","country":"Georgia","geoPoint":{"lat":41.69143,"lon":44.83412}},{"facility":"Investigative Site","city":"Tbilisi","zip":"0114","country":"Georgia","geoPoint":{"lat":41.69143,"lon":44.83412}},{"facility":"Investigative Site","city":"Tbilisi","zip":"0159","country":"Georgia","geoPoint":{"lat":41.69143,"lon":44.83412}},{"facility":"Investigative Site","city":"Frankfurt","zip":"60590","country":"Germany","geoPoint":{"lat":49.68333,"lon":10.53333}},{"facility":"Investigative Site","city":"Hanover","zip":"30625","country":"Germany","geoPoint":{"lat":52.37052,"lon":9.73322}},{"facility":"Investigative Site","city":"Heidelberg","zip":"69120","country":"Germany","geoPoint":{"lat":49.40768,"lon":8.69079}},{"facility":"Investigative Site","city":"Chisinau","zip":"2025","country":"Moldova","geoPoint":{"lat":47.00902,"lon":28.85938}},{"facility":"Investigative Site","city":"Auckland","zip":"1010","country":"New Zealand","geoPoint":{"lat":-36.84853,"lon":174.76349}},{"facility":"Investigative Site","city":"Karachi","zip":"74800","country":"Pakistan","geoPoint":{"lat":24.8608,"lon":67.0104}},{"facility":"Investigative Site","city":"Karachi","zip":"75600","country":"Pakistan","geoPoint":{"lat":24.8608,"lon":67.0104}},{"facility":"Investigative Site","city":"Lahore","zip":"54800","country":"Pakistan","geoPoint":{"lat":31.558,"lon":74.35071}},{"facility":"Investigative Site","city":"Rawalpindi","zip":"46000","country":"Pakistan","geoPoint":{"lat":33.59733,"lon":73.0479}},{"facility":"Investigative Site","city":"Bucharest","zip":"021105","country":"Romania","geoPoint":{"lat":44.43225,"lon":26.10626}},{"facility":"Investigative Site","city":"Bucharest","zip":"022328","country":"Romania","geoPoint":{"lat":44.43225,"lon":26.10626}},{"facility":"Investigative Site","city":"Bucharest","zip":"030303","country":"Romania","geoPoint":{"lat":44.43225,"lon":26.10626}},{"facility":"Investigative Site","city":"Kyiv","zip":"01135","country":"Ukraine","geoPoint":{"lat":50.45466,"lon":30.5238}},{"facility":"Investigative Site","city":"London","zip":"E1 1BB","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"Investigative Site","city":"London","zip":"SE5 9RS","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"Investigative Site","city":"Manchester","zip":"M8 5RB","country":"United Kingdom","geoPoint":{"lat":53.48095,"lon":-2.23743}},{"facility":"Investigative Site","city":"Nottingham","zip":"NG7 2UH","country":"United Kingdom","geoPoint":{"lat":52.9536,"lon":-1.15047}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-02-25"},"conditionBrowseModule":{"meshes":[{"id":"D006505","term":"Hepatitis"},{"id":"D003699","term":"Hepatitis D"},{"id":"D019701","term":"Hepatitis D, Chronic"}],"ancestors":[{"id":"D008107","term":"Liver Diseases"},{"id":"D004066","term":"Digestive System Diseases"},{"id":"D006525","term":"Hepatitis, Viral, Human"},{"id":"D014777","term":"Virus Diseases"},{"id":"D007239","term":"Infections"},{"id":"D012327","term":"RNA Virus Infections"},{"id":"D006521","term":"Hepatitis, Chronic"},{"id":"D002908","term":"Chronic Disease"},{"id":"D020969","term":"Disease Attributes"},{"id":"D010335","term":"Pathologic Processes"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"}]}},"hasResults":false}